Facebook Twitter LinkedIn Google Plus RSS

New SVP for pharmaceutical development at Antares

By ,

Ewing-based Antares Pharma Inc. announced today its appointment of David H. Bergstrom Ph.D. as senior vice president of pharmaceutical development.

According to the announcement, Dr. Bergstrom comes to Antares Pharma from Advantar Laboratories where he was the executive vice president and chief operating officer. Prior to joining Advantar, he was the senior vice president and chief operating officer at NovaDel Pharmaceuticals. He has held several similar roles of progressive authority at multiple pharmaceutical companies.

Also Popular on NJBIZ

Write to the Editorial Department at editorial@njbiz.com

Related Stories

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy